ArticleJournal of child & adolescent trauma2026
Evaluation of an Adverse Childhood Experiences Screening Program for Pregnant Patients in Rural Missouri.
Article in Journal of child & adolescent trauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adverse Childhood Experiences (ACEs) are defined as exposure to traumatic conditions from birth until age 18 years. Exposure to ACEs is associated with poor health outcomes and increased risks of chronic conditions such as obesity, heart disease, diabetes, stroke, and cancer. Pregnant women who have experienced ACEs have increased rates of depression, anxiety, post-traumatic stress symptoms, substance abuse and suicidality. The high prevalence of ACEs justifies screening, early support and interventions. This Quality Improvement Project was an evaluation of an existing ACEs screening program initiated in 2019 at an Obstetrics and Gynecology clinic in Northeast Missouri. It was aimed at screening ACEs in pregnant patients at their prenatal visit, so that timely referrals and resources can be provided to patients with high ACEs scores. The effectiveness of this program was evaluated by screening charts of all the eligible patients January 2021 to March 2021 (Timepoint 1, T1) and January 2022 to March 2022 (Timepoint 2, T2). Of the 144 patients, 50 participants (34.7%) had an ACE score of three or above. There was no statistically significant difference in the ACE scores between T1 and T2 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.